Overview

Dropless Pars Plana Vitrectomy Study

Status:
Not yet recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Treatments:
Atropine
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Polymyxins
Prednisolone
Prednisolone acetate
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Trimethoprim